Teva, Mass. Settle Drug Price-Fixing Suit For $7M

Law360, New York (January 5, 2009, 12:00 AM EST) -- Teva Pharmaceutical USA Inc. has agreed to pay $7 million to settle allegations of drug price-fixing brought by the Massachusetts Attorney General's Office as part of a multidistrict litigation accusing a handful of pharmaceutical companies of falsely inflating the prices of drugs.

The state Attorney General's Office announced the settlement Monday, days after filing a stipulation of dismissal with prejudice regarding Teva and its wholly owned subsidiary Ivax Corp. in the U.S. District Court for the District of Massachusetts.

Under the settlement, Teva will pay $7...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.